Search
for
Sort by
Research 511–540 of 1000+
- Potential Treatment of Steroid‐Resistant Alopecia Areata Using Allogeneic Exosomes Derived From Adipose Tissue Mesenchymal Stromal Cells: A Case Report
- Spatiotemporal immunomodulation by engineered hair follicle stem cell-derived nanovesicles enables scarless regeneration of infected wounds
- Carotid Intima Media Thickness Measurement in Alopecia Areata Patients
- Case report: Dupilumab therapy for alopecia areata in a 4-year-old patient resistant to baricitinib
- Editor's Picks August 2023
- 599 Amelioration of symptoms of dry and eczema-prone skin by an oil-in-water emulsion containing a combination of a zingiber officinale root extract and cbd with antioxidative and anti-inflammatory activity in vitro
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Alopecia Areata: An Updated Review for 2023
- Chronic graft versus host disease and skin
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- 3D bioprinting of engineered exosomes secreted from M2-polarized macrophages through immunomodulatory biomaterial promotes in vivo wound healing and angiogenesis
- Class IIa HDAC4 and HDAC7 cooperatively regulate gene transcription in Th17 cell differentiation
- Developmentally programmed early-age skin localization of iNKT cells supports local tissue development and homeostasis
- Epidermal PPARγ Is a Key Homeostatic Regulator of Cutaneous Inflammation and Barrier Function in Mouse Skin
- Broussonetia papyrifera Promotes Hair Growth Through the Regulation of β-Catenin and STAT6 Target Proteins: A Phototrichogram Analysis of Clinical Samples
- Efficacy of Upadacitinib in Treating Alopecia Areata, Atopic Dermatitis, and Th1 Comorbidities in Pediatric Patients: A Comprehensive Case Series and Literature Review
- Genome-wide association study of atopic and autoimmune comorbidities in alopecia areata
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- 290 Brepocitinib improves cicatricial alopecia and downregulates key T-helper biomarkers
- 019 Herpes simplex virus infection in pemphigus patients: a prospective study
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Natural killer cells in atopic and autoimmune diseases of the skin
- Recent progress in the manipulation of biochemical and biophysical cues for engineering functional tissues
- Targeting Wnt/β-catenin signaling and its interplay with TGF-β and Notch signaling pathways for the treatment of chronic wounds
- Trichohyalin is a Potential Major Autoantigen in Human Alopecia Areata
- Advancements and challenges in stem cell transplantation for regenerative medicine
- Alopecia areata after dupilumab for atopic dermatitis
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata